Transforming The DMTA Cycle Through Enhanced Collaboration
In the rapidly evolving field of drug discovery, efficient teamwork, open communication, and streamlined processes throughout the Design-Make-Test-Analyze (DMTA) cycle are essential.
Join industry experts from Eli Lilly, Acelot and Ikena Oncology for this insightful one-hour discussion that will explore the impact of technology in improving collaboration to enable better insights, a competitive edge, and faster progression through the drug discovery pipeline.
Attendees will gain a better understanding of:
- The most prominent and recent changes in drug discovery
- Technology’s role in improving collaboration between team members, departments, and partnering organizations
- How to choose innovative solutions that are also easy to integrate, accessible and scalable
- The future expectations around AI and Machine Learning